Tutorials › Adaptive Clinical Trial Design › Worked Selection Rule For Binary Outcomes

Treatment Selection and Arm Dropping · Tutorial 390 of 799

Worked Selection Rule For Binary Outcomes

Learn to apply a fixed interim selection rule to binary response rates and use independent validation data with Holm adjustment to assess retained treatments.

Advanced 10 min read

What You'll Learn

  • Calculate interim response rates and risk differences for a pre-specified treatment-ranking rule.
  • Distinguish descriptive interim selection from confirmatory evidence of efficacy.
  • Compute a pooled two-sample score statistic and one-sided p-value for binary outcomes.
  • Apply Holm’s step-down procedure to the retained treatments’ p-values.
  • Explain why independent validation protects against selection bias but does not make approximate p-values exact.
  • Recognize assumptions and diagnostics that can undermine the analysis.

Why Specify the Rule Before Looking at Interim Results?

A trial with several candidate treatments may use an interim analysis to decide which arms continue to confirmatory evaluation. For a binary endpoint, such as response by a specified visit, a simple rule can rank treatments by their observed response rates and retain only those meeting a pre-specified criterion. The rule needs to be fixed in advance: choosing the ranking method, cutoff, or number of arms after seeing the interim data can change which treatments survive.

Selection and confirmation have different jobs. Interim response rates can guide which arms are retained; they do not, by themselves, establish efficacy. Confirmatory tests on a separate validation sample can assess retained treatments while avoiding reuse of the observations that determined selection. Because several treatments may be tested, the confirmatory analysis also needs a multiplicity procedure.

Definition: A pre-specified selection rule is a procedure written before interim outcomes are examined that maps the interim data to a set of retained treatment arms. A binary outcome has two possible values for each participant, such as response or no response, assessed at a defined time point. The response proportion estimates the probability of response in the relevant population under the treatment being studied.

Assumptions and a Concrete Selection Rule

The illustration uses a binary response endpoint, defined consistently across treatment and control arms. Each participant contributes one outcome. Within each arm, outcomes are treated as independent Bernoulli observations with a common response probability. Randomization, consistent outcome ascertainment, and the planned analysis population are assumed. There is no differential missingness in the examples; in an actual trial, the handling of missing outcomes must be specified because excluding or classifying them differently can change response rates.

Suppose the interim rule ranks candidate arms by their observed response-rate difference from control. It retains no more than two arms, and an arm is eligible only if its observed difference is at least 0.05, or five percentage points. Ties are resolved by a fixed arm priority specified in the protocol. This threshold is a selection criterion, not a significance threshold. The rule is descriptive: it does not claim that an eligible arm has a true benefit of at least five percentage points.

Worked Example: Applying the Interim Ranking Rule

Consider a hypothetical interim analysis with 100 participants in each arm. There are three candidates, A, B, and D, and a control arm. The observed numbers of responders are 52 for A, 48 for B, 43 for D, and 40 for control.

The control response rate is \(40/100=0.40\). The candidate response rates and differences from control are:

$$ \begin{aligned} \hat p_A &= 52/100=0.52, & \hat p_A-\hat p_C &= 0.52-0.40=0.12,\\ \hat p_B &= 48/100=0.48, & \hat p_B-\hat p_C &= 0.48-0.40=0.08,\\ \hat p_D &= 43/100=0.43, & \hat p_D-\hat p_C &= 0.43-0.40=0.03. \end{aligned} $$

A and B are the two highest-ranked candidates, and both exceed the 0.05 eligibility cutoff. D does not meet the cutoff. Therefore the rule retains A and B and drops D. These interim differences are used only to apply the pre-specified rule; they are not confirmatory estimates of treatment benefit.

Confirmatory Score Tests for Binary Outcomes

For each retained treatment, consider a one-sided test of whether its response probability exceeds the control response probability. Write the treatment and control probabilities as \(p_T\) and \(p_C\). The hypotheses are \(H_0:p_T\le p_C\) against \(H_a:p_T>p_C\). The two-sample score test evaluates the boundary \(p_T=p_C\), which is the least favorable null value for this upper-tail test.

For independent treatment and control samples of sizes \(n_T\) and \(n_C\), let \(\hat p_T\) and \(\hat p_C\) be their observed response proportions. Under the equality boundary, the pooled estimate is \(\hat p_{\text{pool}}=(x_T+x_C)/(n_T+n_C)\), where \(x_T\) and \(x_C\) are the responder counts. The score statistic and its large-sample one-sided p-value are:

$$ Z= \frac{\hat p_T-\hat p_C} {\sqrt{\hat p_{\text{pool}}(1-\hat p_{\text{pool}}) \left(\frac{1}{n_T}+\frac{1}{n_C}\right)}}, \qquad p_{\text{one-sided}}=1-\Phi(Z). $$

This normal approximation relies on independent observations and sufficiently large expected counts of both responses and nonresponses under the null. It is not an exact finite-sample test. In particular, using a large-sample score p-value does not guarantee exact error-rate control for every possible sample size or data configuration.

Worked Example: Confirmatory Tests in the Validation Sample

Suppose the retained treatments are assessed in independent hypothetical validation cohorts. Each treatment has its own independent control cohort, so the comparisons do not reuse participants from the interim sample or from one another. For A, 90 of 150 participants respond and 66 of 150 controls respond. For B, 101 of 200 respond and 80 of 200 controls respond. The endpoint, follow-up, and outcome definition are the same as at interim.

For A, \(\hat p_A=90/150=0.600\) and \(\hat p_C=66/150=0.440\). The pooled estimate is \((90+66)/(150+150)=156/300=0.520\). Thus:

$$ SE_A=\sqrt{0.520(1-0.520)\left(\frac{1}{150}+\frac{1}{150}\right)} =\sqrt{0.003328}=0.05769, \qquad Z_A=\frac{0.600-0.440}{0.05769}=2.773. $$

The one-sided large-sample p-value is \(1-\Phi(2.773)\approx0.002773\). The observed validation response rate is 16 percentage points higher for A, and the result is inconsistent with the equality boundary at conventional unadjusted levels. This p-value alone does not account for testing multiple retained treatments.

For B, \(\hat p_B=101/200=0.505\), while \(\hat p_C=80/200=0.400\). The pooled estimate is \((101+80)/(200+200)=181/400=0.4525\). Therefore:

$$ SE_B=\sqrt{0.4525(1-0.4525)\left(\frac{1}{200}+\frac{1}{200}\right)} =\sqrt{0.0024774375}=0.04977, \qquad Z_B=\frac{0.505-0.400}{0.04977}=2.110. $$

The one-sided p-value is \(1-\Phi(2.110)\approx0.01745\). The observed difference is 10.5 percentage points in favor of B. Both p-values are approximate because the tests use a normal score approximation; the independent validation design separates these tests from the selection data, but does not make the approximations exact.

Holm Adjustment and the Error-Control Argument

Holm’s step-down procedure adjusts for testing a family of hypotheses while allowing arbitrary dependence among p-values, provided each p-value is valid under its null. For \(m\) hypotheses, sort the p-values as \(p_{(1)}\le\cdots\le p_{(m)}\). Compare \(p_{(1)}\) with \(\alpha/m\). If it exceeds that threshold, reject none. Otherwise reject its hypothesis and compare \(p_{(2)}\) with \(\alpha/(m-1)\), continuing in order. Stop at the first failure; do not reject that hypothesis or any later one.

The reason Holm controls the familywise error rate under valid p-values can be seen directly. Suppose there are \(k\) true null hypotheses. If any true null is rejected, consider the first true null in the ordered list. At its position, at least the \(k\) true-null p-values remain, so the Holm threshold at that position is no larger than \(\alpha/k\). Thus a false rejection implies that at least one true-null p-value is at most \(\alpha/k\). By the union bound and validity of each true-null p-value, the probability of this event is at most \(k(\alpha/k)=\alpha\). This argument gives strong familywise error control, meaning control for any configuration of true and false null hypotheses.

When selection is based only on interim data and validation data are independent of those data, conditioning on the selected set does not alter the validation p-value distributions under their null hypotheses. Consequently, if the confirmatory p-values are valid, Holm controls the conditional familywise error rate at no more than \(\alpha\), and hence also controls the unconditional rate. With the large-sample score tests used here, however, this guarantee is approximate: their p-values are not guaranteed to be super-uniform at finite sample sizes. Exact control requires valid p-values for the design and null being tested.

Worked Example: Applying Holm to the Retained Treatments

Use the two one-sided validation p-values from the preceding example and set the familywise significance level to \(\alpha=0.05\). There are \(m=2\) hypotheses. The ordered p-values are \(p_{(1)}=0.002773\) for A and \(p_{(2)}=0.01745\) for B.

At the first step, the threshold is \(0.05/2=0.025\). Since \(0.002773<0.025\), reject A’s null hypothesis. At the second step, the threshold is \(0.05/(2-1)=0.05\). Since \(0.01745<0.05\), reject B’s null hypothesis as well. Thus both retained treatments meet the Holm-adjusted criterion for superiority, subject to the approximation caveat for the score p-values.

The corresponding Holm-adjusted p-values are approximately 0.005546 for A and 0.01745 for B. For A, the first ordered p-value is multiplied by two. For B, the step-down adjusted value is the larger of \(2(0.002773)\) and \(0.01745\), which is \(0.01745\). These adjusted values summarize the familywise procedure; they are not probabilities that either null hypothesis is true.

Diagnostics, Alternatives, and Limitations

Before interpreting the result, check that the implemented rule matches the protocol: the endpoint and time point are consistent, the ranking uses the stated estimator, the cutoff is applied in the stated direction, and ties are resolved as planned. Reconstruct the counts and denominators for each arm. Unexpected denominator changes, missing outcomes, or inconsistent endpoint coding can alter both interim selection and validation inference.

For the score tests, inspect the responder and nonresponder counts in each group. Very small expected counts make the normal approximation questionable; extreme response rates can also make the approximation less reliable. Examine randomization and data-quality summaries for departures from independence, such as cluster assignment or repeated observations treated as separate participants. If these issues arise, the stated score-test calculation may not be appropriate; a design-appropriate model or valid small-sample test should be specified instead.

The independent validation sample is the central protection against selection affecting confirmatory inference. If the same outcomes are used both to rank arms and to test them, the selected arms tend to have favorable interim noise, and ordinary unadjusted confirmatory p-values need not retain their nominal null behavior. Selection-adjusted procedures and analyses that explicitly account for data reuse are alternatives, but they require methods designed for that dependence.

Holm is a practical alternative to a joint maxT procedure: it is valid under arbitrary dependence when the component p-values are valid, though it may be less powerful when the correlation structure can be used effectively. Bonferroni is simpler but generally no more powerful than Holm. A maxT approach instead uses the joint distribution of test statistics and can exploit known correlation, but its calibration must match the design. None of these multiplicity procedures repairs invalid component p-values, poor outcome measurement, or an unplanned selection rule.

A common mistake is to say, “The validation sample is independent, so Holm guarantees an exact 5% familywise error rate.” Independence addresses the effect of selection on the validation data; it does not turn a normal approximation into an exact p-value. The correction is to distinguish the claims: with valid null p-values, Holm gives the stated bound conditional on selection; with large-sample score p-values, the bound is approximate and depends on the adequacy of the approximation.

Key takeaway: A fixed binary-outcome selection rule can identify arms for further study without treating interim rankings as efficacy evidence. Independent validation data and a multiplicity adjustment support confirmatory claims, but exact error control depends on using valid p-values.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

  1. Under the rule in the first example, what happens if a fourth candidate has an interim difference of 0.06 and ranks above B?
  2. For a one-sided test with two retained arms and \(\alpha=0.05\), what is Holm’s first comparison threshold?
  3. Why does independent validation data help after interim selection, and what does it not guarantee when score-test p-values are used?
  4. Name two checks that would alert an analyst that the stated binary score-test analysis may be unreliable.

Solutions. (1) The fourth candidate is eligible because its difference exceeds 0.05. The rule retains no more than two arms, so the two highest-ranked eligible candidates are retained; if the fourth candidate outranks B, it replaces B. (2) The first threshold is \(\alpha/m=0.05/2=0.025\). (3) Independence means that selection based on interim outcomes does not change the conditional null distribution of the validation outcomes. It does not guarantee that a large-sample score p-value is exactly valid at finite sample sizes, so the Holm error-rate guarantee is approximate with these tests. (4) Examples include very small expected responder or nonresponder counts, missingness or denominator changes, and clustered observations analyzed as independent participants.

Clinical Biostats